C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2004
10/14/2004	US20040202646 Bifunctional glycoproteins having a modified carbohydrate complement and their use in tumor-selective therapy
10/14/2004	US20040202642 E.g., treating or preventing Parkinson's disease or symptoms or associated physiology such as motor deficits or nigrostriatal degeneration inducing nigrostriatal regeneration; especially a vector that expresses GDNF
10/14/2004	US20040202641 Recombinant super-compound interferon
10/14/2004	US20040201840 Method for evaluating uniformity of spots in arrays
10/14/2004	DE10314618A1 Verfahren zur Herstellung von L-Aminosäuren unter Verwendung von Stämmen der Familie Enterobacteriaceae A method for producing L-amino acids using strains of the family Enterobacteriaceae
10/14/2004	DE10295684T9 Verfahren zum spezifischen Hemmen von Histon-Deacetylase-4 Method for the specific inhibition of histone deacetylase 4
10/14/2004	CA2521410A1 Inhibitor proteins of a protease and use thereof
10/14/2004	CA2521393A1 Peptabody for cancer treatment
10/14/2004	CA2521235A1 Improved method of resistance management for transgenic crops
10/14/2004	CA2521075A1 Gene involved in the biosynthesis of carotenoid and marine microorganism, paracoccus haeundaensis, producing the carotenoid
10/14/2004	CA2520936A1 An antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same
10/14/2004	CA2520868A1 Staphylococcus epidermidis antigens
10/14/2004	CA2520846A1 Aptamer selection method
10/14/2004	CA2520811A1 Method of cdna synthesis
10/14/2004	CA2520795A1 Novel plant acyltransferases specific for long-chained, multiply unsaturated fatty acids
10/14/2004	CA2520637A1 Mva virus expressing modified hiv envelope, gag, and pol genes
10/14/2004	CA2520630A1 Method of synthesis and testing of combinatorial libraries using microcapsules
10/14/2004	CA2520479A1 Method and system for rapidly conferring a desired trait to an organism
10/14/2004	CA2520460A1 Use of fgf- 18 protein, target proteins and their respective encoding nucleotide sequences to induce cartilage formation
10/14/2004	CA2520396A1 Pufa polyketide synthase systems and uses thereof
10/14/2004	CA2520386A1 Nontypeable haemophilus influenzae virulence factors
10/14/2004	CA2520181A1 Selected rna motifs to include cell death and/or apoptosis
10/14/2004	CA2520170A1 Method for the in vivo modification of the synthesis activity of a metabolite by means of the modification of a gene the activity of which is not the original activity
10/14/2004	CA2519912A1 Regulatory regions that promote early plant seed enhanced transcription
10/14/2004	CA2519674A1 Genomic profiling of regulatory factor binding sites
10/14/2004	CA2519368A1 Statistical analysis of regulatory factor binding sites of differentially expressed genes
10/14/2004	CA2519309A1 Dna polymerase fusions and uses thereof
10/13/2004	EP1467207A1 Screening method
10/13/2004	EP1466988A2 Genes and gene expression products that are differentially regulated in prostate cancer
10/13/2004	EP1466982A1 Pyroglutamyl peptidase and its gene
10/13/2004	EP1466981A1 Glycosyle hydrolyse genes and uses thereof for the biodegradation of carraghenane
10/13/2004	EP1466980A1 Lipase and use of same for improving doughs and baked products
10/13/2004	EP1466979A1 Fungus-origin lysyl oxidases
10/13/2004	EP1466978A1 Chitin oligosaccharide elicitor and gibberellin responsive genes in plant and utilization thereof
10/13/2004	EP1466977A1 Methods and compositions for inhibiting neoplastic cell growth
10/13/2004	EP1466976A1 PROCESS FOR PRODUCING KiSS-1 PEPTIDE
10/13/2004	EP1466975A1 Postsynaptic proteins
10/13/2004	EP1466974A1 Inducible site-directed mutagenesis through conditional gene rescue
10/13/2004	EP1466972A1 Nucleotide sequences having activity of controlling translation efficiency and utilization thereof
10/13/2004	EP1466970A1 Alkaline protease
10/13/2004	EP1466962A1 Alkaline protease
10/13/2004	EP1466624A1 Drug for regenerating tissue and vessel and method therefor
10/13/2004	EP1466618A1 Treatment for diabetes
10/13/2004	EP1466616A2 Use of CASB616 polypeptides and polynucleotides for cancer treatment
10/13/2004	EP1466175A2 SPHKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
10/13/2004	EP1466174A2 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571
10/13/2004	EP1466018A2 Use of silica material in an amplification reaction
10/13/2004	EP1466017A2 Tissue rejection
10/13/2004	EP1466016A2 Cancer profiles
10/13/2004	EP1466015A2 Bioconjugate-nanoparticle probes
10/13/2004	EP1466013A2 Thermus scotoductus nucleic acid polymerases
10/13/2004	EP1466001A2 Viruses with enhanced lytic potency medikament
10/13/2004	EP1466000A2 Regulation of gene transcription by the variable number of tandem repeats (vntr) domain of the dopamine transporter gene
10/13/2004	EP1465999A2 Fusion proteins
10/13/2004	EP1465998A2 Single nucleotide polymorphisms predicting cardiovascular disease and medication efficacy
10/13/2004	EP1465997A2 Use of biomolecular targets in the treatment and visualization of tumors
10/13/2004	EP1465996A2 Raf/ras binding compounds
10/13/2004	EP1465995A1 Bispecific antisense olignucleotides that inhibit igfbp-2 and igfbp-5 and methods of using same
10/13/2004	EP1465994A2 Rabbit nuclear cloning method and uses thereof
10/13/2004	EP1465993A2 Inducible transposition in transgenic organism using transposon vector
10/13/2004	EP1465990A2 Truncated lysostaphin molecule with enhanced staphylolytic activity
10/13/2004	EP1465988A2 Myo-inositol oxygenases
10/13/2004	EP1465986A1 Gfp-transfected clon pig, gt knock-out clon pig and methods for production thereof
10/13/2004	EP1465985A2 High level cytokine production with enhanced cell viability
10/13/2004	EP1465981A2 Methods and compositions for generating a genetically modified animal using lentiviral vectors
10/13/2004	EP1465927A2 Bag3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases
10/13/2004	EP1465926A2 Methods for blocking or alleviating staphylococcal nasal colonization by intranasal application of monoclonal antibodies
10/13/2004	EP1465925A2 Antibodies that immunospecifically bind to trail receptors
10/13/2004	EP1465924A2 Modulators of notch ic protease activity for use in immunotherapy
10/13/2004	EP1465923A1 Corticotropin releasing factor receptor 2 agonists
10/13/2004	EP1465922A2 Corticotropin releasing factor receptor 2 agonists
10/13/2004	EP1465921A2 Corticotropin releasing factor receptor 2 agonists
10/13/2004	EP1465920A2 Mammalian simp protein, gene sequence and uses thereof in cancer therapy
10/13/2004	EP1465919A2 Insect g protein-coupled receptor genes and uses thereof
10/13/2004	EP1465916A2 Novel g proein-coupled receptor, gave7
10/13/2004	EP1465913A1 Heteroconfigurational polynucleotide and methods of use
10/13/2004	EP1465912A2 Novel chimeric tnf ligands
10/13/2004	EP1465911A2 Compositions and methods for diagnosing and treating diabetes, insulin resistance and dyslipidemia
10/13/2004	EP1465910A2 Rna interference mediated inhibition of checkpoint kinase-1 (chk-1) gene expression using short interfering nucleic acid
10/13/2004	EP1465908A2 Compositions and methods for hydroxylating epothilones
10/13/2004	EP1465906A1 Compositions and methods relating to endometrial specific genes and proteins
10/13/2004	EP1465905A2 Antisense modulation of myd88 expression
10/13/2004	EP1465659A2 Use of a novel cell surface protease from group b streptococcus
10/13/2004	EP1465651A1 Use of c-jun or c-jun activating agents such as uv or c-jun n-terminal kinases (junks) for treating cancer
10/13/2004	EP1465650A2 Sk-3 potassium channels and the treatment of sexual dysfunctions and/or vascular disorders
10/13/2004	EP1465599A1 Liposome composition for delivery of nucleic acid
10/13/2004	EP1465578A2 Antisense modulation of vascular endothelial growth factor receptor-1 expression
10/13/2004	EP1465493A1 Cultured and encapsulated pancreatic stem cells
10/13/2004	EP1465481A1 Knockout swine and methods for making the same
10/13/2004	EP1404862A4 Thermostable proteinases from thermophilic bacteria
10/13/2004	EP1362235A4 Peptide or protein microassay method and apparatus
10/13/2004	EP1322309A4 High affinity small molecule c5a receptor modulators
10/13/2004	EP1309240A4 Nucleic acid expression from linear nucleic acids
10/13/2004	EP1287164B1 A filter element for use in separation of biomaterials from solid contaminants
10/13/2004	EP1286682A4 Methods and compositions for inhibiting immunoglobulin-mediated--reperfusion injury
10/13/2004	EP1280820B1 Anti-inflammatory compounds and uses thereof
10/13/2004	EP1268770B1 Method for isolating plasmids from suspended bacterial cells
10/13/2004	EP1257584B1 Humanized antibodies that sequester amyloid beta peptide
10/13/2004	EP1230374A4 Modification of polysaccharide containing materials
10/13/2004	EP1203014B1 Peptide antagonists of factor viia

1 ... 2157 2158 2159 2160 2161 2162 2163 2164 2165 2166 2167 2168 2169 2170 2171 2172 2173 2174 2175 2176 2177 ... 4023